Lidocaine release from polycaprolactone threads

Industrie Biomediche Insubri S/A, Via Cantonale, Mezzovico, Ticino, Switzerland
Journal of Applied Polymer Science (Impact Factor: 1.64). 01/2010; 117(6):3610 - 3614. DOI: 10.1002/app.32262

ABSTRACT In the field of resorbable devices, drug eluting sutures represent an applied research field on which the reliability of both production processes and mathematical prediction modeling were tested. Indeed, poly-ε-caprolactone pellets were compounded with lidocaine and then extruded to obtain highly loaded threads. The complete and rapid release demonstrated that the extrusion process does not alter the drug, which is confirmed to be embedded in an open porous matrix, being free to be solvated by uptaken water and to diffuse. Release profile and polymer degradation were simulated through a mathematical model based on conservation laws that allowed to assess release kinetic and to confirm the understanding of involved phenomena, as it fit experimental data. Reliability and robustness of chosen model allow to monitor the overall quality of manufacturing because any discrepancy between experimental and simulated data can be adopted to assess drug distribution uniformity within the device. © 2010 Wiley Periodicals, Inc. J Appl Polym Sci, 2010

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Bacterial infections on a sutured wound represent a critical problem, and the preparation of suture threads possessing antimicrobial properties is valuable. In this work, poly(caprolactone) (PCL) monofilaments were compounded at the concentration of 1, 2 and 4 % (w/w), respectively, to the antiseptic chlorhexidine diacetate (CHX). The incorporation was carried out in the melt by a single-step methodology, i.e. "online" approach. Mechanical tests revealed that the incorporation of CHX does not significantly change tensile properties of PCL fibres as the thermal profile adopted to prepare the compounded fibres does not compromise the antibacterial activity of CHX. In fact, CHX confers to compounded PCL fibres' antimicrobial property even at the lowest CHX concentration as revealed by microbiological assays performed on Escherichia coli, Micrococcus luteus and Bacillus subtilis strains. The scanning electron microscope micrographs and energy-dispersive X-ray analysis of compounded threads revealed that CHX is uniformly distributed on fibre surface and that the overall amount of superficial CHX increases by increasing compounded CHX concentration. This distribution determines a biphasic CHX release kinetics characterized by an initial rapid solubilisation of superficial CHX micro-crystals, followed by a slow and gradual release of CHX incorporated in the bulk. Interestingly, the compounded threads did not show any toxic effect compromising cell viability of human fibroblasts in vitro, differently from that observed using an equal amount of pure CHX. Thus, this study originally demonstrated the effectiveness of an "online" approach to confer antimicrobial properties to an organic thermoplastic polymeric material commonly used for medical devices.
    Applied Microbiology and Biotechnology 07/2012; 97(1). DOI:10.1007/s00253-012-4283-x
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The role of phosphate buffer saline solution (PBS) was investigated here as a solvent in the polycondensation synthesis of an injectable agar-carbomer based hydrogel, a promising new material specifically intended for regenerative medicine applications. The effects of PBS, with respect to standard distilled water (DW), were quantitatively assessed. Experiments were performed both from physico-chemical and biological points of view. Titration showed higher stability due to the presence of the buffer solution; ESEM analysis confirmed its distribution along the polymeric fibers and infrared spectroscopy showed the consequent anionic nature of the polymeric network. This electrostatic nature of the matrix was confirmed by mass equilibrium swelling data performed at different pH values of the swelling medium. A very relevant role of the solvent was observed also with respect to cell housing inside such hydrogels: living cell counts showed a high amount of cells surviving the latency period of encapsulation in hydrogel when PBS was applied while only very few survived in a deionized water based gel. Obtained data allowed a novel understanding of the causeeffect cascades of all observed phenomena which suggest the PBS fundamental role both in fine control of hydrogel preparation and in material tuning according to the specific needs of different target tissues; the latter being a feature of primary importance when applying hydrogels as cell carriers in regenerative medicine applications. Keywordshydrogels-phosphate buffered saline solution-cell housing-agar-carbomer
    Chemical Papers- Slovak Academy of Sciences 10/2010; 64(5):573-578. DOI:10.2478/s11696-010-0052-4
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper aims to provide a comprehensive review of the various models or simulations for predicting drug release from bulk-degrading systems. A brief description of bulk degradation processes and factors affecting the degradation rate, and consequently the release kinetics, is presented first. Next, several important classical models, often used as the basis for subsequent model development, are discussed. Both mathematical models and Monte-Carlo based simulations have been developed for controlled release from bulk-degrading systems. The mathematical models can be further subdivided into two categories. First, the diffusion-based models whose transport mechanism is mainly governed by diffusion, but with degradation-dependent diffusion coefficients. These are generally simpler and easier to use and are sufficient to illustrate mono-phasic release. Second, comprehensive models that combine diffusion with other theories such as erosion, drug dissolution and/or pore percolations. These models usually involve more complex equations but provide good matches for multi-phasic release profiles.
    International Journal of Pharmaceutics 12/2010; 418(1):28-41. DOI:10.1016/j.ijpharm.2010.12.020